Stock Market Movers and Today Trending Buzz

 StocksRunner
 
  StocksRunner
 
Follow  Message
 
 
 
Find out what happening right now and get all the pieces of the puzzle on important data activity before the major news sources break the story and see what are the trends
 

•  20 Mar 2025
 

General Mills $GIS is in the spotlight following a mixed third-quarter earnings report that revealed a 5% drop in revenue to $4.84 billion—falling short of Wall Street's expectations. Despite the revenue miss, the company managed to deliver a Non-GAAP EPS of $1.00, beating estimates by $0.04. However, the real concern for investors lies in the company’s slashed FY25 guidance. General Mills is warning of slowing snacking demand, which is casting a shadow over future sales and profitability. This cautious outlook is putting pressure on the stock, with shares tumbling as analysts weigh the implications of weaker consumer demand and a more uncertain economic environment. Despite delivering some positive earnings surprises, the market remains focused on the lowered guidance and concerns about future growth.

Meanwhile, Boeing ($BA) is enjoying a strong rally after its CFO delivered an upbeat outlook at an investor conference. The aerospace giant’s cash burn is easing, and factory performance is improving—welcome news after months of operational concerns. Boeing’s stock surged over 5%, marking its best day in nearly two years. Investors are cheering the company’s affirmation of its delivery targets, with the positive sentiment extending to key suppliers. Adding fuel to the fire, Japan Airlines announced an order for 17 single-aisle Boeing planes, further strengthening confidence in the company's recovery. Despite ongoing worries about tariffs and supply chain challenges, the optimistic cash flow guidance has provided a major boost to the stock’s momentum.

CVS Health ($CVS) is also grabbing attention, with its stock climbing after a notable improvement in price performance. The healthcare giant earned an upgrade to its IBD Relative Strength Rating, signaling growing confidence in the stock’s trajectory. However, the picture isn’t entirely rosy—deep-pocketed investors are reportedly adopting a bearish stance on CVS, with public options data revealing significant bets against the stock. Questions about long-term profitability and the potential impact of recession risks are keeping some investors on edge. Still, for now, the upward momentum is helping CVS regain ground after a challenging period.

Finally, Sportradar ($SRAD) is making headlines with its announcement to acquire IMG ARENA and its portfolio of global sports betting rights. This strategic acquisition aims to strengthen Sportradar’s foothold in the fast-growing sports betting market. The move comes on the heels of a strong fiscal year, with the company reporting a 26% increase in revenue and rising adjusted EBITDA for FY24. Investors appear to be embracing the acquisition as a catalyst for future growth, positioning Sportradar as a key player in the rapidly evolving sports tech and data space.